Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonstructural protein 5A (NS5A) is a multifunctional, zinc-binding hydrophilic phosphoprotein essential for the replication and assembly of the Hepatitis C virus (HCV). Although NS5A lacks intrinsic enzymatic activity, it functions as a key component of the viral replication complex by interacting with other viral proteins (such as NS5B polymerase and NS4B) and host cellular factors (such as cyclophilin A and phosphatidylinositol 4-kinase III alpha). NS5A is also involved in modulating host immune responses, particularly by inhibiting the interferon-induced antiviral pathway, which promotes viral persistence. Direct-acting antivirals (DAAs) targeting NS5A, known as NS5A inhibitors (e.g., daclatasvir, ledipasvir, velpatasvir), bind to Domain I of the protein, disrupting both viral RNA replication and virion assembly. These drugs are highly potent and are used in combination regimens to achieve high rates of sustained virologic response (SVR) in chronic hepatitis C patients.
Inhibits the NS5A protein, disrupting the formation and function of the viral replication complex and interfering with viral RNA replication and virion assembly.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nonstructural protein 5A (NS5A).